selected scholarly activity
-
academic article
- Correction: Specialised Paediatric PAlliativE CaRe: Assessing family, healthcare professionals and health system outcomes in a multi-site context of various care settings: SPhAERA study protocol. BMC Palliative Care. 22:13. 2023
- Cancer burden in adolescents and young adults in Europe. ESMO Open. 8:100744-100744. 2023
- Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey‐based cross‐sectional study. Cancer Reports. 6:e1649. 2023
- Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE. The Lancet Oncology. 23:1537-1546. 2022
- Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review. BMC Cancer. 22:267. 2022
- Specialised Paediatric PAlliativE CaRe: Assessing family, healthcare professionals and health system outcomes in a multi-site context of various care settings: SPhAERA study protocol. BMC Palliative Care. 21:188. 2022
- Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors. Endocrine Reviews Recent Progress in Hormone Research. 43:794-823. 2022
- A national survey of Swiss paediatric oncology care providers’ cross-cultural competences. Swiss Medical Weekly Schweizerische Medizinische Wochenschrift. 152:w30223-w30223. 2022
- Feasibility of a registry for standardized assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer. Scientific Reports. 12:14617. 2022
- Childhood cancer and traffic-related air pollution in Switzerland: A nationwide census-based cohort study. Environmental International. 166:107380-107380. 2022
- Novel Pharmacological Treatment Options in Pediatric Glioblastoma—A Systematic Review. Cancers. 14:2814-2814. 2022
- Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes. Journal of Neuro-Oncology. 157:307-317. 2022
- Correction to: Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes. Journal of Neuro-Oncology. 157:319-319. 2022
- Long-Term Follow-Up of Pediatric CNS Tumor Survivors—A Selection of Relevant Long-Term Issues. Children. 9:447-447. 2022
- Educational Attainment and Employment Outcome of Survivors of Pediatric CNS Tumors in Switzerland—A Report from the Swiss Childhood Cancer Survivor Study. Children. 9:411-411. 2022
- Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 57:207-214. 2022
- Back to school – The teachers’ worries and needs having a childhood cancer patient or survivor in their class. Frontiers in Oncology. 12:992584. 2022
- Cancer knowledge and health-consciousness in childhood cancer survivors following transition into adult care—results from the ACCS project. Frontiers in Oncology. 12:946281. 2022
- Determining transition readiness in Swiss childhood cancer survivors – a feasibility study. BMC Cancer. 21:84. 2021
- Predicting fever in neutropenia with safety‐relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study. Pediatric Blood and Cancer Medical and Pediatric Oncology. 68:e29253. 2021
- Validation of questionnaire-reported chest wall abnormalities with a telephone interview in Swiss childhood cancer survivors. BMC Cancer. 21:787. 2021
- Young Survivors at KSA: registry for standardised assessment of long-term and late-onset health events in survivors of childhood and adolescent cancer—a study protocol. BMJ Open. 11:e053749-e053749. 2021
- Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. European Journal of Cancer. 156:127-137. 2021
- Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet Oncology. 22:e196-e206. 2021
- Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation—a cohort study. Bone Marrow Transplantation. 56:1065-1076. 2021
- Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study. European Journal of Cancer. 145:71-80. 2021
- Transition from pediatric to adult follow-up care in childhood cancer survivors—a systematic review. Journal of Cancer Survivorship. 15:151-162. 2021
- Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Journal of Cancer Survivorship. 14:923-938. 2020
- Perception of Inpatient Oncologic Rehabilitation in Children, Adolescents and Young Adults Diagnosed with Cancer in Switzerland. Klinische Padiatrie. 232:294-299. 2020
- Aftercare of Childhood Cancer Survivors in Switzerland: Protocol for a Prospective Multicenter Observational Study. JMIR Research Protocols. 9:e18898-e18898. 2020
- Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC). Journal of Neuro-Oncology. 149:45-54. 2020
- 39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial. The Lancet Child & Adolescent Health. 4:495-502. 2020
- Melanotic neuroectodermal tumor of infancy to the skull: case-based review. Child's Nervous System. 36:679-688. 2020
- Médecine intégrative en oncologie pédiatrique. Revue Medicale Suisse. 16:2293-2296. 2020
- The Pediatric Toronto Extremity Salvage Score (pTESS): Validation of a Self-reported Functional Outcomes Tool for Children with Extremity Tumors. Clinical Orthopaedics and Related Research. 477:2127-2141. 2019
- Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers. Quality of Life Research. 28:515-521. 2019
- Relationship status and quality of the partner relationship in parents of long‐term childhood cancer survivors: The Swiss Childhood Cancer Survivor Study‐Parents. Psycho-Oncology. 28:309-316. 2019
- Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. The Lancet Oncology. 20:e29-e41. 2019
- Surveillance imaging for high-grade childhood brain tumors: What to do 10 years after completion of treatment?. Pediatric Blood and Cancer Medical and Pediatric Oncology. 65:e27311-e27311. 2018
- Survival Following Tumor Recurrence in Children With Medulloblastoma. Journal of Pediatric Hematology/Oncology. 40:e159-e163. 2018
- Audiological monitoring in Swiss childhood cancer patients. Pediatric Blood and Cancer Medical and Pediatric Oncology. 65:e26877-e26877. 2018
- Spatial clustering of childhood cancers in Switzerland: a nationwide study. Cancer Causes and Control. 29:353-362. 2018
- Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome. Acta Neuropathologica. 134:705-714. 2017
- Household income and risk-of-poverty of parents of long-term childhood cancer survivors. Pediatric Blood and Cancer Medical and Pediatric Oncology. 64:e26456-e26456. 2017
- Analysis of surgical and MRI factors associated with cerebellar mutism. Journal of Neuro-Oncology. 133:539-552. 2017
- Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study. PLoS ONE. 12. 2017
- Adiposity in childhood brain tumors: A report from the Canadian Study of Determinants of Endometabolic Health in Children (CanDECIDE Study). Scientific Reports. 7:45078. 2017
- Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. Journal of Neuro-Oncology. 132:155-162. 2017
- Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training. Neuro-Oncology. 19:now177-now177. 2017
- Long-term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study. Pediatric Blood and Cancer Medical and Pediatric Oncology. 64:364-373. 2017
- Grandparents: A hardly recognized part of the childhood cancer family. Pediatric Blood and Cancer Medical and Pediatric Oncology. 64:9-10. 2017
- Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study. PLoS ONE. 12:e0174479-e0174479. 2017
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 30:891-908. 2016
- Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study. Journal of Clinical Oncology. 34:3537-3543. 2016
- Pediatric oncologists' coping strategies for dealing with patient death. Journal of Psychosocial Oncology. 34:39-59. 2016
- When a child dies: pediatric oncologists' follow-up practices with families after the death of their child. Psycho-Oncology. 24:1626-1631. 2015
- Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive. Journal of Neuro-Oncology. 124:247-253. 2015
- Challenging patient deaths in pediatric oncology. Supportive Care in Cancer. 23:2349-2356. 2015
- Neurocognitive evaluation of long term survivors of atypical teratoid rhabdoid tumors (ATRT): The Canadian registry experience. Pediatric Blood and Cancer Medical and Pediatric Oncology. 62:1265-1269. 2015
- EZH2 expression is a prognostic factor in childhood intracranial ependymoma: A Canadian Pediatric Brain Tumor Consortium study. Cancer. 121:1499-1507. 2015
- Sedentary Time and Screen-Based Sedentary Behaviors of Children With a Chronic Disease. Pediatric Exercise Science. 27:219-225. 2015
- Challenges Faced by Pediatric Oncology Fellows When Patients Die During Their Training. Journal of Oncology Practice. 11:e182-e189. 2015
- Grief reactions and impact of patient death on pediatric oncologists. Pediatric Blood and Cancer Medical and Pediatric Oncology. 62:134-142. 2015
- Incidence of medulloblastoma in Canadian children. Journal of Neuro-Oncology. 120:575-579. 2014
- Recruitment feasibility to a cohort study of endocrine and metabolic health among survivors of childhood brain tumours: a report from the Canadian study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE). BMJ Open. 4:e005295-e005295. 2014
- Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nature Genetics. 46:451-456. 2014
- Considering quality of life for children with cancer: a systematic review of patient-reported outcome measures and the development of a conceptual model. Quality of Life Research. 23:771-789. 2014
- Testicular Myeloid Sarcoma. Journal of Pediatric Hematology/Oncology. 36:e155-e157. 2014
- Medulloblastoma stem cells: Modeling tumor heterogeneity. Cancer Letters. 338:23-31. 2013
- FoxG1 Interacts with Bmi1 to Regulate Self-Renewal and Tumorigenicity of Medulloblastoma Stem Cells. Stem Cells. 31:1266-1277. 2013
- Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours. BMJ Open. 3:e002869-e002869. 2013
- Optic pathway gliomas in adolescence--time to challenge treatment choices?. Neuro-Oncology. 15:391-400. 2013
- Favorable outcome with conservative treatment for children with low grade brainstem tumors. Pediatric Blood and Cancer Medical and Pediatric Oncology. 58:556-560. 2012
- Medulloblastoma stem cells: where development and cancer cross pathways. Pediatric Research. 71:516-522. 2012
- Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience. European Journal of Cancer. 48:353-359. 2012
- Combined Staged Endoscopic and Microsurgical Approach of a Third Ventricular Choroid Plexus Papilloma in an Infant. Minimally Invasive Neurosurgery. 54:264-267. 2011
- BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma. Clinical Cancer Research. 17:4790-4798. 2011
- Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas. Pediatric Blood and Cancer Medical and Pediatric Oncology. 57:84-88. 2011
- 42nd Congress of the International Society of Pediatric Oncology (SIOP) in Boston: A tribute to the two pioneers in pediatric oncology. Pediatric Blood and Cancer Medical and Pediatric Oncology. 55:773-774. 2010
- Macrophage activation syndrome/hemophagocytic lymphohistiocytosis and Kawasaki disease. Pediatric Blood and Cancer Medical and Pediatric Oncology. 55:592-592. 2010
- “Handbook of Madeira” and “Marine Worms of Madeira”: The less known publications by Paul Langerhans!. Pediatric Blood and Cancer Medical and Pediatric Oncology. 55:593-594. 2010
- Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Supportive Care in Cancer. 18:913-919. 2010
- Isolated Central Nervous System Relapse in Childhood Acute Promyelocytic Leukemia. Journal of Pediatric Hematology/Oncology. 30:160-162. 2008
- Is There a Benefit of Preoperative Meningioma Embolization?. Neurosurgery. 47:1306-1312. 2000
-
book
-
chapter
- Neurocognitive Dysfunction and Psychosocial Issues. 1149-1160. 2019
- Low grade glioma. 91-99. 2015
- Pediatric Neuro-oncology. ix. 2015
- Pediatric neuro-oncology in countries with limited resources. 299-307. 2015
- Abdominal Masses. 31-35. 2012
- Initial Management of New Diagnosis. 5-12. 2012
- Introduction: Pediatric Oncology. 1-4. 2012
- Mediastinal Mass and Superior Vena Cava Syndrome. 25-30. 2012
- Procedures. 55-62. 2012
- Spinal Cord Compression and Cauda Equina Syndrome. 37-41. 2012
-
conference paper
- Adiposity and depressive symptoms in survivors of childhood brain tumors: A report from the Canadian study of the determinants of endometabolic health in children. Journal of the Neurological Sciences. 746-746. 2017
- Time Trends in Hearing Loss after Childhood Cancer. Pediatric Blood and Cancer Medical and Pediatric Oncology. S76-S77. 2016
- A MODEL OF CARE FOR PEDIATRIC CNS TUMOR PATIENTS. Neuro-Oncology. 149-149. 2016
- ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?. Neuro-Oncology. 1-1. 2016
- DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?. Neuro-Oncology. 40-40. 2016
- IS A SEPARATE AFTERCARE CLINIC FOR PEDIATRIC CNS TUMOR PATIENTS NECESSARY?. Neuro-Oncology. 150-150. 2016
- MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM. Neuro-Oncology. 16-16. 2016
- NEURAL NETWORK DISTURBANCES IN CHILDREN TREATED FOR BRAIN TUMOURS. Neuro-Oncology. 154-154. 2016
- PAEDIATRIC SPINAL EPENDYMOMA IN CANADA: A MULTICENTRE RETROSPECTIVE STUDY. Neuro-Oncology. 39-39. 2016
- RELAPSE PATTERNS IN PEDIATRIC INTRACRANIAL EPENDYMOMA: A CANADIAN EXPERIENCE. Neuro-Oncology. 39-39. 2016
- EARLY POST-OPERATIVE MRI FOLLOWING A RESECTION OF A PEDIATRIC BRAIN TUMOR - WHAT IS THE RIGHT TIMEPOINT?. Pediatric Blood and Cancer Medical and Pediatric Oncology. S283-S283. 2015
- OUTCOME OF NEUROFIBROMATOSIS TYPE 1 PATIENTS TREATED WITH FIRST LINE VINBLASTINE FOR OPTIC PATHWAY GLIOMAS (OPG): A CANADIAN MULTICENTER STUDY. Pediatric Blood and Cancer Medical and Pediatric Oncology. S148-S148. 2015
- QUALITY OF LIFE IN CHILDREN WITH LOW-GRADE GLIOMA RECEIVING VINBLASTINE AS FIRST-LINE TREATMENT: A CANADIAN MULTICENTER STUDY. Pediatric Blood and Cancer Medical and Pediatric Oncology. S277-S277. 2015
- RADIATION NECROSIS IN CHILDREN - AN UNDERREPORTED PROBLEM?!. Pediatric Blood and Cancer Medical and Pediatric Oncology. S282-S283. 2015
- THE EFFECTIVENESS OF LIFESTYLE INTERVENTION, PHARMACOTHERAPY OR BARIATRIC SURGERY ON LOWERING BMI Z-SCORE IN OBESE SURVIVORS OF CHILDHOOD BRAIN TUMORS: A SYSTEMATIC REVIEW. Pediatric Blood and Cancer Medical and Pediatric Oncology. S282-S282. 2015
- RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY. Neuro-Oncology. 18-19. 2015
- Outcome of neurofibromatosis type 1 patients treated with first line vinblastine for optic pathway gliomas: A Canadian multicenter study.. Journal of Clinical Oncology. 2019-2019. 2015
- CAN-COL-BRAIN-KIDS: WORK IN PROGRESS ... WHAT HAVE WE LEARNED?. Pediatric Blood and Cancer Medical and Pediatric Oncology. S186-S186. 2014
- NEUROCOGNITIVE EVALUATION OF LONG TERM SURVIVORS WITH ATYPICAL TERATOID RHABDOID TUMOR (ATRT): THE CANADIAN REGISTRY EXPERIENCE. Pediatric Blood and Cancer Medical and Pediatric Oncology. S281-S282. 2014
- CLINICAL AND MOLECULAR DETERMINANTS OF LONG-TERM SURVIVAL IN CHILDREN WITH LOW GRADE GLIOMA; A POPULATION BASED STUDY. Neuro-Oncology. 69-69. 2014
- NEUROCOGNITIVE EVALUATION OF LONG TERM SURVIVOR'S WITH ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): THE CANADIAN REGISTRY EXPERIENCE. Neuro-Oncology. 2-2. 2014
- PROGNOSTIC ADVANTAGE OF SURVEILLANCE NEUROIMAGING IN MANAGEMENT OF PEDIATRIC BRAIN TUMOURS. Neuro-Oncology. 123-123. 2014
- VERY LONG-TERM SURVIVAL OF PAEDIATRIC LOW GRADE GLIOMA PATIENTS; POSSIBLE ROLE OF BRAF-KIAA1549 FUSION. Neuro-Oncology. 171-172. 2013
- WEEKLY VINBLASTINE IN CHEMOTHERAPY NAIVE CHILDREN AND ADOLESCENT WITH UNRESECTABLE OR PROGRESSIVE LOW GRADE GLIOMA: A CANADIAN COOPERATIVE STUDY. Neuro-Oncology. 165-166. 2013
- BRAF ALTERATIONS PREDICT LONG-TERM OUTCOME IN SURVIVORS OF PAEDIATRIC LOW GRADE GLIOMA. Pediatric Blood and Cancer Medical and Pediatric Oncology. 161-162. 2013
- CANCOL-BRAIN-KIDS: COLLABORATION BETWEEN CANADA AND COLOMBIA FOR PEDIATRIC CNS TUMORS. Pediatric Blood and Cancer Medical and Pediatric Oncology. 140-141. 2013
- OBESITY AND IMMUNITY IN SURVIVORS OF CHILDHOOD BRAIN TUMORS: A PRELIMINARY REPORT. Pediatric Blood and Cancer Medical and Pediatric Oncology. 142-142. 2013
- WEEKLY VINBLASTINE IN CHEMOTHERAPY NAIVE CHILDREN WITH UNRESECTABLE OR PROGRESSIVE LOW GRADE GLIOMA: A CANADIAN COOPERATIVE STUDY. Pediatric Blood and Cancer Medical and Pediatric Oncology. 19-19. 2013
- Weekly vinblastine in chemotherapy-naive children with unresectable or progressive low grade glioma: A Canadian cooperative study. Journal of Clinical Oncology. 2013
- CLONAL EVOLUTION OF MEDULLOBLASTOMA BRAIN TUMOUR-INITIATING CELLS (BTICS) IN RESPONSE TO THERAPY: DISCOVERING THE REFRACTORY BTIC POPULATION. Neuro-Oncology. 27-27. 2013
- REGULATION OF MEDULLOBLASTOMA STEM CELL SELF-RENEWAL THROUGH THE DEVELOPMENTALLY CONSERVED FoxG1-Bmi1-p21 AXIS. Neuro-Oncology. 21-21. 2013
- Development of a Conceptual Model of Quality of Life within Pediatric Oncology. The International Journal of Qualitative Methods. 744-744. 2013
- IMPORTANT FACTORS TO UNDERSTANDING QUALITY OF LIFE ACCORDING TO CHILDREN WITH CANCER AND CHILDHOOD CANCER SURVIVORS. Pediatric Blood and Cancer Medical and Pediatric Oncology. 1120-1120. 2012
- Bmi1 REGULATION OF SONIC HEDGEHOG SIGNALING THROUGH THE E3 UBIQUITIN LIGASE CULLIN3 IN MEDULLOBLASTOMA STEM CELLS. Neuro-Oncology. 94-94. 2012
- CHILDREN SURVIVING BRAIN TUMORS HAVE HIGH RATES OF OBESITY INDEPENDENT OF PUBERTY. Neuro-Oncology. 131-131. 2012
- DEVELOPMENT OF IN VITRO AND IN VIVO CHEMO-AND RADIOTHERAPY MODELS FOR DETECTION OF TREATMENT-REFRACTORY MEDULLOBLASTOMA BRAIN TUMOR-INITIATING CELLS. Neuro-Oncology. 94-94. 2012
- FITNESS, PHYSICAL ACTIVITY AND BODY COMPOSITION FOLLOWING TREATMENT FOR A CNS TUMOUR. Neuro-Oncology. 134-135. 2012
- FRACTIONATED STEREOTACTIC RADIOSURGERY FOR RELAPSED PAEDIATRIC PRIMITIVE NEUROECTODERMAL TUMOURS: A SINGLE INSTITUTION EXPERIENCE. Neuro-Oncology. 146-146. 2012
- INCIDENCE OF MEDULLOBLASTOMA IN CANADIAN CHILDREN. Neuro-Oncology. 46-46. 2012
- PARENTAL KNOWLEDGE AND HEALTH CARE SATISFACTION WITH NEUROFIBROMATOSIS TYPE 1. Neuro-Oncology. 129-129. 2012
- PEDIATRIC AND ADULT MEDULLOBLASTOMA: WHAT MAKES THE DIFFERENCE IN OUTCOME?. Neuro-Oncology. 86-86. 2012
- PEDIATRIC INTRACRANIAL GERMINOMA CASE SERIES: FOUR PATIENTS WITH ATYPICAL CLINICO-RADIOLOGICAL PRESENTATION. Neuro-Oncology. 54-54. 2012
- BRAF-KIAA1549 FUSION PREDICTS BETTER CLINICAL OUTCOME IN PEDIATRIC LOW-GRADE ASTROCYTOMA. Neuro-Oncology. I28-I28. 2011
- LONG TERM SURVIVOR OF PEDIATRIC LOW GRADE GLIOMA - WHAT IS THEIR OWN AND THEIR FAMILIES' QUALITY OF LI. Pediatric Blood and Cancer Medical and Pediatric Oncology. 939-939. 2010
- CNS ATYPICAL RHABDOID TUMOUR: THE CANADIAN PEDIATRIC BRAIN TUMOR CONSORTIUM EXPERIENCE. Neuro-Oncology. II36-II36. 2010
- GLIOMATOSIS CEREBRI IN CHILDREN-A MULTIFACETED DISEASE. Pediatric Blood and Cancer Medical and Pediatric Oncology. 856-857. 2010
- MANAGEMENT OF AN INTRACRANIAL MATURE TERATOMA RECURRING AS A GERMINOMA. Neuro-Oncology. II133-II133. 2010
- MEDULLOBLASTOMA OVER THREE DECADES IN A SINGLE INSTITUTION - WHAT HAVE WE ACHIEVED. Neuro-Oncology. II61-II61. 2010
- MORBIDITY IN LONG TERM SURVIVORS (> 10 YEARS) OF PEDIATRIC LOW GRADE GLIOMA. Neuro-Oncology. II98-II98. 2010
- MORTALITY IN PEDIATRIC LOW GRADE GLIOMA - A 25 YEARS POPULATION BASED STUDY. Neuro-Oncology. II96-II96. 2010
- PEDIATRIC NEUROONCOLOGY IN CANADA - DO WE HAVE A STANDARD OF CARE?. Neuro-Oncology. II81-II81. 2010
- SALVAGE REPEATED CHEMOTHERAPY FOR PEDIATRIC PROGRESSIVE LOW-GRADE GLIOMAS: A POPULATION BASED STUDY. Pediatric Blood and Cancer Medical and Pediatric Oncology. 848-849. 2010
- THE CANADIAN PAEDIATRIC BRAIN TUMOUR CONSORTIUM (CPBTC): A NATIONAL NETWORK USING TELECONFERENCING. Neuro-Oncology. II17-II18. 2010
- Survival and functional outcome of childhood spinal cord low-grade gliomas. Journal of Neurosurgery: Pediatrics. 254-261. 2009
- A population-based epidemiological study of childhood low-grade glioma. Neuro-Oncology. 410-410. 2008
- Feasibility and efficacy of second-line chemotherapy at recurrence for pediatric low-grade gliomas: A comparative population-based study. Neuro-Oncology. 447-448. 2008
- High morbidity but low mortality in childhood spinal cord gliomas. Neuro-Oncology. 448-448. 2008
- Feasibility and efficacy of second-line chemotherapy at recurrence for pediatric low-grade gliomas: A comparative population-based study. Journal of Clinical Oncology. 2069-2069. 2008